Edwards Lifesciences Corporation (BIT:1EW)

Edwards Lifesciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	40,883	42,594	37,491	39,435	39,049	69,565
Market Cap Growth	-3.39%	13.61%	-4.93%	0.99%	-43.87%	41.96%
Enterprise Value	37,841	39,564	34,728	38,680	38,599	68,897
PE Ratio	44.71	46.58	10.62	33.15	30.58	54.43
Forward PE	27.51	30.93	31.19	28.41	30.35	52.98
PEG Ratio	-	3.24	3.69	2.77	2.95	3.38
PS Ratio	7.91	8.16	8.01	9.15	10.17	15.45
PB Ratio	4.64	4.79	4.36	6.89	7.82	13.85
P/TBV Ratio	4.11	4.83	4.44	6.99	8.02	14.01
P/FCF Ratio	35.96	37.08	150.31	71.30	46.62	57.49
P/OCF Ratio	30.09	31.03	80.35	51.17	37.26	46.68
EV/Sales Ratio	7.23	7.58	7.42	8.97	10.05	15.30
EV/EBITDA Ratio	24.06	32.36	26.31	30.92	27.39	43.87
EV/EBIT Ratio	26.80	36.37	29.28	34.35	29.94	47.37
EV/FCF Ratio	33.28	34.44	139.23	69.94	46.08	56.94
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.12	0.12
Debt / EBITDA Ratio	0.50	0.50	0.46	0.47	0.42	0.38
Debt / FCF Ratio	0.53	0.53	2.42	1.07	0.71	0.49
Net Debt / Equity Ratio	-0.34	-0.34	-0.33	-0.14	-0.09	-0.13
Net Debt / EBITDA Ratio	-2.48	-2.48	-2.14	-0.65	-0.32	-0.42
Net Debt / FCF Ratio	-2.64	-2.64	-11.30	-1.47	-0.54	-0.55
Asset Turnover	0.45	0.45	0.49	0.57	0.53	0.66
Inventory Turnover	1.21	1.21	1.12	1.10	0.90	1.63
Quick Ratio	2.83	2.83	3.12	2.06	1.87	2.07
Current Ratio	3.72	3.72	4.18	3.38	3.03	3.08
Return on Equity (ROE)	20.90%	20.90%	66.58%	41.82%	48.89%	28.88%
Return on Assets (ROA)	7.84%	7.84%	11.09%	13.18%	15.55%	18.97%
Return on Invested Capital (ROIC)	13.73%	13.73%	17.40%	18.23%	21.56%	27.15%
Return on Capital Employed (ROCE)	10.79%	10.79%	13.98%	16.96%	20.33%	24.47%
Earnings Yield	2.24%	2.15%	9.42%	3.02%	3.27%	1.84%
FCF Yield	2.78%	2.70%	0.67%	1.40%	2.15%	1.74%
Buyback Yield / Dilution	1.50%	1.45%	2.25%	1.55%	3.48%	0.44%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.